Pyxis Oncology, Inc. (PYXS)
1.96
+0.02
(+1.03%)
USD |
NASDAQ |
May 22, 16:00
1.96
0.00 (0.00%)
After-Hours: 20:00
Pyxis Oncology EPS Diluted (Quarterly) : -0.3667 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NanoViricides, Inc. | -0.0921 |
| Organogenesis Holdings, Inc. | -0.4394 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.27M |
| Total Expenses (Quarterly) | 23.27M |
| Enterprise Value | 99.94M |
| Earnings Yield | -66.51% |
| Normalized Earnings Yield | -66.51 |